false 0001733413 0001733413 2025-03-03 2025-03-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): March 3, 2025

 

 

 

TFF PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-39102   82-4344737
(State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification Number)

 

124 Washington Street, Suite 101

Foxborough, MA 02035

(Address of principal executive offices)

 

(508) 543-1720

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14d-2(b)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

Securities registered pursuant to Section 12(b)of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock: Par value $.001   TFFP   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On March 3, 2025, TFF Pharmaceuticals, Inc. (“Company”) held a Special Meeting of Stockholders for the purpose of approving the dissolution of the Company in accordance with Section 275 of the Delaware General Corporation Law and the Plan of Dissolution previously distributed to the Company’s stockholders in connection with the Special Meeting (the “Plan of Dissolution”).

 

The Company’s stockholders approved the Plan of Dissolution, with shares voted as follows:

 

For   4,725,319 
Against   100,218 
Abstain   2,929 

 

There were no broker non-votes on the approval of the Plan of Dissolution.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TFF PHARMACEUTICALS, INC.
   
   
Dated: March 6, 2025 /s/  Craig Jalbert
  Craig Jalbert,
  President and Chief Executive Officer

 

 

2

 

v3.25.0.1
Cover
Mar. 03, 2025
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 03, 2025
Entity File Number 001-39102
Entity Registrant Name TFF PHARMACEUTICALS, INC.
Entity Central Index Key 0001733413
Entity Tax Identification Number 82-4344737
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 124 Washington Street
Entity Address, Address Line Two Suite 101
Entity Address, City or Town Foxborough
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02035
City Area Code 508
Local Phone Number 543-1720
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock: Par value $.001
Trading Symbol TFFP
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
TFF Pharmaceuticals (NASDAQ:TFFP)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more TFF Pharmaceuticals Charts.
TFF Pharmaceuticals (NASDAQ:TFFP)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more TFF Pharmaceuticals Charts.